NDA submitted to FDA for MDS
Celgene has announced it has submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for its investigational drug Revlimid, a first in a new class of novel immunomodulatory drugs, or ImiDs.
Archives for April 11, 2005
CeNeS and Tripos advances COMT research
CeNeS Pharmaceuticals and Tripos have entered into a new agreement to continue their collaboration on COMT inhibitors, which represent a new breed of therapy for Parkinson's disease and other psychotic disorders such as schizophrenia.
Invitrogen co-markets infection detection system.
Invitrogen and Agilent have entered into an agreement to co-market an infectious agent detection system, which has shown to be sensitive and specific for the identification of air and waterborne pathogens.
Gut bugs could determine individualised therapies
The success of personalised healthcare depends on a better understanding of how gut microbes interact with different medicines, according to scientists, who believe that the microflora makeup of an individual has been overlooked when compared to the...
Dispenser takes guesswork out of ointment dosing
Pharmaceuticals delivered out of a tube such as creams and ointments are widely used, but suffer from a key drawback: it is almost impossible to deliver an accurate dose.
Merrion wins EU patent for drug delivery system
Merrion Pharmaceuticals, formed last year from the drug delivery business of Ireland's Elan, has been awarded a key European on the technology underlying one of its delivery systems, reports Phil Taylor.
Scientists identify "common diseases" gene
Researchers have identified a common gene variant that could be a risk factor behind a number of common diseases such as cardiovascular disease, rheumatism and Multiple Sclerosis (MS), of which up to a quarter of the population could be affected.
Ticona launches next-generation COC for multilayer films
Ticona has enhanced its Topas COC (cyclic olefin copolymer) to give blown film producers greater processing flexibility and the ability to make highly transparent films that are practically free of gels.
Sun Pharma buys MJ to help tackle Euro markets
Sun Pharmaceutical Industries is to acquire the entire business of fellow Indian pharmaceutical company MJ Pharmaceuticals in another example of the consolidation affecting the country's fragmented pharmaceutical sector, writes Phil Taylor.